These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25646098)

  • 1. Investor drought and regulatory headwinds slow device innovation.
    Russell S
    Health Aff (Millwood); 2015 Feb; 34(2):199-202. PubMed ID: 25646098
    [No Abstract]   [Full Text] [Related]  

  • 2. Directing capital of value-makers: what investors want.
    Hessler FA
    Hosp Health Netw; 2013 May; 87(5):62. PubMed ID: 23814958
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomedical innovation in the era of health care spending constraints.
    Robinson JC
    Health Aff (Millwood); 2015 Feb; 34(2):203-9. PubMed ID: 25646099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to value technological innovation: a proposal for determining relative clinical value.
    Ladabaum U; Brill JV; Sonnenberg A; Shaheen NJ; Inadomi J; Wilcox CM; Park WG; Hur C; Pasricha PJ
    Gastroenterology; 2013 Jan; 144(1):5-8. PubMed ID: 23153872
    [No Abstract]   [Full Text] [Related]  

  • 5. Market watch: a framework for biomedical innovation in emerging markets.
    Gautam A; Yang S
    Nat Rev Drug Discov; 2014 Sep; 13(9):646-7. PubMed ID: 25176427
    [No Abstract]   [Full Text] [Related]  

  • 6. Capital punishment. Equity drought hits technology and service firms.
    Pallarito K
    Mod Healthc; 1998 Nov; 28(47):56. PubMed ID: 10187700
    [No Abstract]   [Full Text] [Related]  

  • 7. The Italian industry: meeting today's challenges.
    Galavotti P
    Med Device Technol; 2008; 19(3):52-3. PubMed ID: 18557411
    [No Abstract]   [Full Text] [Related]  

  • 8. The promise of biomedical innovation.
    Weil AR
    Health Aff (Millwood); 2015 Feb; 34(2):198. PubMed ID: 25646097
    [No Abstract]   [Full Text] [Related]  

  • 9. [2012, the hybridization is making progress].
    Kiefer B
    Rev Med Suisse; 2013 Jan; 9(368):88. PubMed ID: 23367715
    [No Abstract]   [Full Text] [Related]  

  • 10. Tapping private equity. More providers hope to join the party.
    Becker C
    Mod Healthc; 2007 Jun; 37(23):38-9. PubMed ID: 17607909
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical technologies can carry big payoff, big costs. How to assess needs and build strategies.
    Carpenter D
    Trustee; 2008; 61(7):8-12, 14, 19 passim. PubMed ID: 18773556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rise of European venture capital for biotechnology.
    Howell M; Trull M; Dibner MD
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract]   [Full Text] [Related]  

  • 13. Making the right long-term prescription for medical equipment financing.
    Conbeer GP
    Healthc Financ Manage; 2007 Jun; 61(6):88-93. PubMed ID: 17571713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stampede to convertibles.
    Jacobs T
    Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquiring a new analyzer.
    Blacketer J; Redman W
    MLO Med Lab Obs; 2012 Apr; 44(4):24, 26-7. PubMed ID: 22586851
    [No Abstract]   [Full Text] [Related]  

  • 16. Capital: beyond the tried and true.
    Carpenter D
    Hosp Health Netw; 2005 Jun; 79(6):34-8, 40, 2. PubMed ID: 16047620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospering by standardizing processes and improving the patient experience.
    Kaplan G; Robeznieks A
    Mod Healthc; 2014 Jan; 44(2):28-9. PubMed ID: 24693751
    [No Abstract]   [Full Text] [Related]  

  • 18. Positioning hospitals for improved access to capital.
    Ponton KT; Sandrick KM
    Healthc Financ Manage; 2002 Nov; 56(11):52-8. PubMed ID: 12656030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative plan lets 2 financially troubled hospitals gain access to capital markets.
    Graham J
    Mod Healthc; 1987 Apr; 17(8):108. PubMed ID: 10281460
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of Venture Capital Investment in Therapeutic Otolaryngologic Devices, 2008-2017.
    Rathi VK; Murr AH; Feng AL; Tauscher JL; Naunheim MR; Kozin ED; Gray ST
    JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):387-389. PubMed ID: 30816918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.